Reno Protective Effect of Sodium Glucose Cotransporter-2 Inhibitor (Dapagliflozin) in Type 2 Diabetic Patients
Abdelmoniem, R., Shaalan, M., Shawky, M., lbrahim, W., Elbadawy, A. (2022). Reno Protective Effect of Sodium Glucose Cotransporter-2 Inhibitor (Dapagliflozin) in Type 2 Diabetic Patients. EKB Journal Management System, 88(1), 2923-2929. doi: 10.21608/ejhm.2022.242996
Rasha O. Abdelmoniem; Marwa S. Shaalan; M. Shawky; Walaa M. lbrahim; Ayman M. Elbadawy. "Reno Protective Effect of Sodium Glucose Cotransporter-2 Inhibitor (Dapagliflozin) in Type 2 Diabetic Patients". EKB Journal Management System, 88, 1, 2022, 2923-2929. doi: 10.21608/ejhm.2022.242996
Abdelmoniem, R., Shaalan, M., Shawky, M., lbrahim, W., Elbadawy, A. (2022). 'Reno Protective Effect of Sodium Glucose Cotransporter-2 Inhibitor (Dapagliflozin) in Type 2 Diabetic Patients', EKB Journal Management System, 88(1), pp. 2923-2929. doi: 10.21608/ejhm.2022.242996
Abdelmoniem, R., Shaalan, M., Shawky, M., lbrahim, W., Elbadawy, A. Reno Protective Effect of Sodium Glucose Cotransporter-2 Inhibitor (Dapagliflozin) in Type 2 Diabetic Patients. EKB Journal Management System, 2022; 88(1): 2923-2929. doi: 10.21608/ejhm.2022.242996